Improving Therapeutic Adherence With a Co-constructed Program Involving Both Patients and Health Care Professionals

Civil Hospices of Lyon

Status: Enrolling

Conditions: Cystic Fibrosis

Treatments: Other: " Information-Motivation-Behavioral skills " intervention.

Study type: Interventional

Funder types: Other

Identifiers

NCT03226795

69HCL17_0279

Details and patient eligibility

About

Background Cystic fibrosis is a life-threatening genetic disorder responsible for pulmonary failure and multi-systemic complications involving specific and large medical care burden. To date, no program has shown its effectiveness in improving therapeutic adherence. A new approach to develop a co-constructed program involving patients and professionals may contribute to improve therapeutic adherence.

Objectives The aim of the MUCOBS-Trial project is to create a program to increase therapeutic adherence and to evaluate its efficacy in adult patients with cystic fibrosis in 3 CF centers in France.

Enrollment: 450 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with Cystic Fibrosis
• Aged 18 or more
• Speaking / understanding French
• Followed in one of the participating centers (CRCM of the Auvergne-Rhône-Alpes region)
• Resident in Auvergne-Rhône-Alpes
• Affiliated to the general health insurance scheme

Exclusion criteria

• Transplanted Patients
• Patients who participated in the working group for the co-construction of the intervention

Trial design

Primary purpose: Health Services Research

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

450 participants in 1 patient group

interventional arm

Experimental group

Treatment:

Other: " Information-Motivation-Behavioral skills " intervention.